Official UK visa sponsor profile for Autifony Therapeutics in Stevenage, including current register status, route details, and public company data.
Autifony Therapeutics is a limited company (Ltd) registered in England and Wales with registration number 07543962. It was established on February 25, 2011, and currently maintains an active status. The company’s registered address is located at Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, SG1 2FX. Autifony Therapeutics operates within the biotechnology sector, specifically focusing on research and experimental development. Its core business involves translating scientific discoveries into new treatments, with a particular emphasis on rare central nervous system (CNS) disorders. The company utilizes an ion channel platform and employs pioneering scientific expertise in this endeavor. Company size is not explicitly stated on the website, but is described as “not specified.” It is a research and experimental development company. The company’s financial status as of September 30, 2024, indicates no charges and is not insolvent. Autifony Therapeutics holds a Skilled Worker visa and possesses a Worker (A rating). The company’s international presence is not specified. It is currently active.
Official UK visa sponsor profile for Autifony Therapeutics in Stevenage, including current register status, route details, and public company data.
Autifony Therapeutics is a limited company (Ltd) registered in England and Wales with registration number 07543962. It was established on February 25, 2011, and currently maintains an active status. The company’s registered address is located at Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, SG1 2FX. Autifony Therapeutics operates within the biotechnology sector, specifically focusing on research and experimental development. Its core business involves translating scientific discoveries into new treatments, with a particular emphasis on rare central nervous system (CNS) disorders. The company utilizes an ion channel platform and employs pioneering scientific expertise in this endeavor. Company size is not explicitly stated on the website, but is described as “not specified.” It is a research and experimental development company. The company’s financial status as of September 30, 2024, indicates no charges and is not insolvent. Autifony Therapeutics holds a Skilled Worker visa and possesses a Worker (A rating). The company’s international presence is not specified. It is currently active.
Yes, Autifony Therapeutics is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Autifony Therapeutics is classified under: Research and experimental development on biotechnology.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, Autifony Therapeutics is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Autifony Therapeutics is classified under: Research and experimental development on biotechnology.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.